Table 3.
CpG residues | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||||||||||
Amplicon 3 | Amplicon 4 | ||||||||||||||||||
Number | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 |
| |||||||||||||||||||
GD12 | 0 | 0 | 0 | 0 | 0 | 70† | 90† | 90† | 60† | 60† | 50† | 70† | 20 | 10 | 0 | 0 | 60† | 80† | 70† |
| |||||||||||||||||||
GD13 | 0 | 0 | 0 | 0 | 0 | 20† | 40† | 40† | 30† | 30† | 20† | 30† | 20 | 0 | 0 | 0 | 100† | 100† | 100† |
| |||||||||||||||||||
GD14 | 0 | 0 | 10 | 0 | 0 | 30 | 30 | 40 | 40 | 40 | 40 | 70† | 11 | 0 | 0 | 0 | 89 | 100 | 100 |
CpG residues that exhibit >25% change in methylation levels between adjacent gestational days.